{"DataElement":{"publicId":"5055936","version":"1","preferredName":"Prior Cellular Therapy Infusion Procedure Performed Source Name","preferredDefinition":"A description of the prior cellular therapy source or origin.","longName":"5054254v1.0:5055934v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"5054254","version":"1","preferredName":"Prior Cellular Therapy Infusion Procedure Performed","preferredDefinition":"Earlier in time or order._Utilization of specific cells, modified or not, for treatment of diseases. Donor lymphocyte infusion is a type of cellular therapy._A method of putting fluids, including drugs, into the bloodstream._Executed and carried through to completion.","longName":"5054252v1.0:2241241v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"5054252","version":"1","preferredName":"Prior Cellular Therapy Infusion Procedure","preferredDefinition":"Earlier in time or order.:Utilization of specific cells, modified or not, for treatment of diseases. Donor lymphocyte infusion is a type of cellular therapy.:A method of putting fluids, including drugs, into the bloodstream.","longName":"C25629:C70601:C15388","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prior","conceptCode":"C25629","definition":"Earlier in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Cellular Therapy","conceptCode":"C70601","definition":"Utilization of specific cells, modified or not, for treatment of diseases. Donor lymphocyte infusion is a type of cellular therapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Infusion Procedure","conceptCode":"C15388","definition":"Any form of treatment that is introduced into the body via a blood vessel, a muscle, or the spinal cord.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"256052A7-BFF5-AE24-E050-BB89AD432175","latestVersionIndicator":"Yes","beginDate":"2015-11-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-11-25","modifiedBy":"ONEDATA","dateModified":"2015-11-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2241241","version":"1","preferredName":"Performed","preferredDefinition":"Performed; carried out.","longName":"C38000","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Performed","conceptCode":"C38000","definition":"Executed and carried through to completion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FA7953-8839-043D-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-07-08","modifiedBy":"ONEDATA","dateModified":"2005-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"256052A7-C003-AE24-E050-BB89AD432175","latestVersionIndicator":"Yes","beginDate":"2015-11-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-11-25","modifiedBy":"NYCHM","dateModified":"2016-07-25","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5055934","version":"1","preferredName":"Cellular Therapy Source Name","preferredDefinition":"Utilization of specific cells, modified or not, for treatment of diseases. Donor lymphocyte infusion is a type of cellular therapy._Where something is available or from where it originates._The words or language units by which a thing is known.","longName":"5055934v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Autologous","valueDescription":"autologous","ValueMeaning":{"publicId":"2568334","version":"1","preferredName":"autologous","longName":"2568334","preferredDefinition":"Taken from an individual's own tissues, cells, or DNA.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Autologous","conceptCode":"C28000","definition":"Taken from an individual's own tissues, cells, or DNA.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D7FB-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-02-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-02","modifiedBy":"COOPERM","dateModified":"2016-02-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"25C3CFA3-ECE0-97E1-E050-BB89AD437D1C","beginDate":"2006-06-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-11-30","modifiedBy":"ONEDATA","dateModified":"2015-11-30","deletedIndicator":"No"},{"value":"Allogeneic, related","valueDescription":"Related Allogenic","ValueMeaning":{"publicId":"2730899","version":"1","preferredName":"Related Allogenic","longName":"2730899","preferredDefinition":"Related; connected or associated.: Taken from different individuals of the same species.  Also called allogeneic.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Relationship","conceptCode":"C25648","definition":"A state of connectedness between people, objects, or events; to be associated or connected with something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Allogeneic","conceptCode":"C28343","definition":"Taken from different individuals of the same species.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"46ADC95C-E156-452D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALEYR","dateCreated":"2008-02-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"25C3CFA3-ECCC-97E1-E050-BB89AD437D1C","beginDate":"2006-06-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-11-30","modifiedBy":"ONEDATA","dateModified":"2015-11-30","deletedIndicator":"No"},{"value":"Allogeneic, unrelated","valueDescription":"Unrelated Allogenic","ValueMeaning":{"publicId":"2730898","version":"1","preferredName":"Unrelated Allogenic","longName":"2730898","preferredDefinition":"Unrelated; not connected or associated e.g. by kinship.: Taken from different individuals of the same species.  Also called allogeneic.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unrelated","conceptCode":"C25328","definition":"Not connected or associated e.g. by kinship.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Allogeneic","conceptCode":"C28343","definition":"Taken from different individuals of the same species.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"46ADC95C-E119-452D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALEYR","dateCreated":"2008-02-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"25C3CFA3-ECD6-97E1-E050-BB89AD437D1C","beginDate":"2006-06-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-11-30","modifiedBy":"ONEDATA","dateModified":"2015-11-30","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"5055933","version":"1","preferredName":"Cellular Therapy Source Name","preferredDefinition":"Utilization of specific cells, modified or not, for treatment of diseases. Donor lymphocyte infusion is a type of cellular therapy.:Where something is available or from where it originates.:The words or language units by which a thing is known.","longName":"C70601:C25683:C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cellular Therapy","conceptCode":"C70601","definition":"Utilization of specific cells, modified or not, for treatment of diseases. Donor lymphocyte infusion is a type of cellular therapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Source","conceptCode":"C25683","definition":"Where something is available or from where it originates.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"25C3CFA3-ECA5-97E1-E050-BB89AD437D1C","latestVersionIndicator":"Yes","beginDate":"2015-11-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-11-30","modifiedBy":"ONEDATA","dateModified":"2015-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"25C3CFA3-ECB6-97E1-E050-BB89AD437D1C","latestVersionIndicator":"Yes","beginDate":"2015-11-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-11-30","modifiedBy":"NYCHM","dateModified":"2016-07-25","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685478","version":"1","longName":"Testing Set – Moderately Different","context":"NCIP"}]}],"AlternateNames":[{"name":"CPRE_HXM_pr_cti_cl_src","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_PCTM_pr_cti_cl_src","type":"NMDP_FN","context":"NHLBI"},{"name":"SubstanceExtractionAdministrationRelationship:relationCode","type":"HCT_BRIDG_5","context":"NHLBI"},{"name":"PreTed_PCT_pr_cti_cl_src","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What was the prior cellular t","type":"Preferred Question Text","description":"What was the prior cellular therapy source?","url":null,"context":"NHLBI"},{"name":"What was the cell source for the prior cellular therapy?","type":"Alternate Question Text","description":"What was the cell source for the prior cellular therapy?","url":null,"context":"NHLBI"},{"name":"What was the cell source for the prior cellular therapy?","type":"Application Standard Question Text","description":"What was the cell source for the prior cellular therapy?","url":null,"context":"NHLBI"},{"name":"Specify the source(s) for the prior cellular therapy","type":"Alternate Question Text","description":"Specify the source(s) for the prior cellular therapy","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"25C3CFA3-ECEB-97E1-E050-BB89AD437D1C","latestVersionIndicator":"Yes","beginDate":"2015-11-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-11-30","modifiedBy":"KUMMEROA","dateModified":"2019-08-30","changeDescription":"Added HCT_BRIDG5 alternate name - RR 2018-12-23","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}